Max Healthcare Q1 profit up 17 pc at ₹345 cr
The healthcare major reported a profit after tax (PAT) of ₹ 295 crore in the April-June period last year.
Gross revenue rose to ₹ 2,574 crore in the quarter from ₹ 2,028 crore in the year-ago period, Max Healthcare said in a statement.
Net debt at June-end stood at ₹ 1,755 crore as compared with ₹ 1,576 crore on March 31, 2025.
The company said its board has approved execution of an agreement to lease a built-to-suit 130-bed hospital in Dehradun.
The proposed facility will be located near the company's existing 220-bed hospital, which is operational since 2012.
Scheduled for commissioning in 2028, the new hospital will, among other specialties, focus on advanced oncology services, including radiation therapy, it said.
Besides, Jaypee Healthcare Ltd, a wholly-owned subsidiary, has executed a binding term sheet to divest Chitta (Bulandshahr) and Anoopshahr hospitals to Manush Aushadi and Anusandan Ltd for ₹ 40 crore, subject to working capital adjustment at closing.
This move is in line with the company's strategy to concentrate on super-specialty care in larger cities, it said.
"Our sustained growth is a reflection of our strategy and execution capabilities," Max Healthcare Institute Chairman and Managing Director Abhay Soi said.
The commissioning of 160-bed brownfield tower at Max Mohali, along with additional brownfield capacities coming online at Max Smart and Nanavati-Max shortly, will significantly enhance clinical and financial performance of the network, he added.
"In parallel, we are scaling up our clinical and support teams, while optimizing our service mix to ensure rapid and effective utilisation of the new capacities," Soi stated.
Shares of the company were trading 0.24 per cent up at ₹ 1,265 apiece on BSE.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
&w=3840&q=100)
Business Standard
9 minutes ago
- Business Standard
Cognizant to roll out pay hikes for 80% employees from November 1
IT services firm Cognizant, during its second quarter earnings call on Thursday, said that 80 per cent of its eligible employees will receive salary hikes, effective November 1. According to a PTI report, the company plans to award merit-based salary hikes to a major chunk of its employees in the second half of 2025. A company spokesperson told PTI that these hikes will be delivered up to the Senior Associate levels. The increase will vary depending on the employee's individual performance and the country. The pay hikes for consistent high performers is likely to be in higher single digits in India, whereas top performers are expected to get the highest raise, the spokesperson said. "These increases will be delivered up to, and including, the Senior Associate levels. The amount of these increases will vary depending on individual performance rating and country," a Cognizant spokesperson said on Thursday. In March this year, Cognizant paid one of the highest bonuses to most of its associates in three years. The bonuses were to the tune of 85-115 per cent. IT majors tread cautiously Cognizant's move follows a similar announcement by Tata Consultancy Services (TCS), which recently said it will be providing salary hikes to most of its employees from September 1. As reported earlier by Business Standard, TCS was the first company to stall hikes in April because of an unfavourable and uncertain macroeconomic environment. According to media reports, Cognizant had also postponed employee appraisals for a second time in March in an attempt to curb attrition. The implementation was expected in August. Indian IT firms under strain Indian IT services companies are grappling with a sluggish global economy, geopolitical tensions, and tariff concerns, prompting delays in appraisals and workforce reductions. Last month, TCS announced one of its biggest layoffs, letting go of about 2 per cent or 12,260 employees of its 613,069 global workforce. The move, aimed at making the company more agile, marks only the second large-scale layoff in TCS's history. The previous one was in 2012, when about 2,500 employees were dismissed for underperformance.
&w=3840&q=100)
Business Standard
9 minutes ago
- Business Standard
Deepak Nitrite shares slip 4% on posting weak Q1 results; key details
Deepak Nitrite shares slipped 4.3 per cent on Wednesday, August 14, 2025, logging an intra-day low at ₹1,785 per share on BSE. The selling pressure on the counter came after the company posted its Q1 results. At 11:59 AM, Deepak Nitrite share price was trading 2.55 per cent lower at ₹1,824.85 per share. In comparison, the Sensex was 0.1 per cent higher at 80,617.55. Deepak Nitrite Q1 results The company reported a net profit of ₹112.2 crore for Q1FY26, compared to ₹202.54 crore in the year-ago period, down 44 per cent. Revenue from operations rose 66.3 per cent year-on-year (YoY) to ₹1,889.88 crore in Q1FY26 from ₹2,166.84 crore in Q1FY25, down 12.7 per cent. Deepak Nitrite's earnings before interest, taxes, depreciation, and amortisation (Ebitda) slipped 40 per cent YoY to ₹197 crore, as compared to ₹328 crore. Ebitda margins stood at 11 per cent, as compared to 15 per cent a year ago. "The chemical industry faced a challenging environment in Q1 FY26, primarily driven by a global economic deceleration and continued oversupply from China. This resulted in pricing pressure and compressed margins across various product lines," the company said in a statement. The agrochemicals segment, in particular, saw a slower-than-expected recovery, especially in Europe, amid cautious purchasing behaviour from global customers. These factors, combined with evolving geopolitical tensions and sluggish demand in major economies, created a volatile backdrop. Check List of Q1 results today Deepak Nitrite management outlook The company said that various initiatives are underway to enhance the margins, like cost optimisation, digital transformation, new product variants, and capacity enhancement, which will drive sustainable growth and long-term profitability. It added: The company is well-positioned for a stable performance going forward, driven by the anticipated recovery in agrochemicals and the strategic ramp-up of new capacities. About Deepak Nitrite Deepak Nitrite is a leading chemical intermediates producer with a diversified portfolio that caters to the dyes and pigments, agrochemical, pharmaceutical, plastics, textiles, paper, and home and personal care segments and petrol derivatives intermediates - phenolics, acetone, and IPA in India and overseas. Its products are manufactured across 6 locations, which are all accredited by Responsible Care.
Mint
9 minutes ago
- Mint
IOC share price dips ahead of Q1 results. How to trade Maharatna PSU stock now?
IOC share price: Shares of public sector undertaking (PSU), Indian Oil Corporation Limited (IOC), traded with a mild cut ahead of the Q1 results announcement for the financial year 2025-26 (FY26). The Maharatna PSU stock declined over 1% to hit the day's low of ₹ 140.75 on the BSE. IOC share price opened marginally higher than the last closing price at ₹ 142.55 apiece. But it soon erased gains and traded marginally lower. The fall came despite expectations of a sharp surge in IOC's Q1 profit. Domestic brokerages see up to 275% despite a decline in net sales on a year-on-year (YoY) basis. IOC's EBITDA is expected to grow significantly compared to last year and last quarter. However, its profit margin from refining (GRM) may go down this quarter because it benefited from some unusual gains earlier that won't happen again. Brokerage Kotak Institutional Equities expects IOC's Q1 FY26 PAT to grow 276% YoY to ₹ 9944.4 crore, compared with ₹ 2643.2 crore posted in the corresponding quarter a year ago. Meanwhile, the figure could grow 37% quarter-on-quarter (QoQ). Net sales could decline 6.2% YoY and 7% QoQ to ₹ 1,81,324.7 crore during the quarter under review. The brokerage said that although oil prices dropped 11-12% QoQ in this quarter, the government's increase in fuel taxes had only a small effect. The rise in domestic LPG prices helped balance things out, it added. Meanwhile, Emkay Global sees a 159% YoY rise in IOC's Q1 profit to ₹ 6852.1 crore while it expects sales to decline by 10% to ₹ 173,897.5 crore during the said period. It expects core GRM of $7.5/bbl and reported GRM of $5.0/bbl, with blended marketing margin at ₹ 8.9/kg, up from ₹ 6.3/kg in Q4. The total sales volume could rise to 3% YoY to 26.1 MMT. According to Anshul Jain, Head of Research, Lakshmishree Investment, post a 143-day cup-and-handle breakout, IOC stock is retesting its base breakout and currently trading slightly below the breakout neckline. 'The earlier move to the upside was supported by higher volumes, while the present pullback is unfolding on lower volumes — a classic sign of a healthy bullish retracement. This pattern suggests that selling pressure is limited and that buyers may soon regain control,' said Jain. The 135–140 zone presents a strong accumulation opportunity for positional longs, with the potential for an upside move toward 171.65 in the coming weeks, he advised. Disclaimer: This story is for educational purposes only. The views and recommendations expressed are those of individual analysts or broking firms, not Mint. We advise investors to consult with certified experts before making any investment decisions, as market conditions can change rapidly and circumstances may vary.
